FDA Inspection
Lily C. Chao, M.D.Lily C. Chao, M.D. – FDA Inspection, Sep 25, 2025
Record Details
This FDA Inspection record concerns Lily C. Chao, M.D., with an inspection on September 25, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 2aa3cae6-6e3e-4325-9068-438a6e82abad
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1283602
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lily C. Chao, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 15, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Lily C. Chao, M.D.
- FDA Inspection 1175781 - 2022-07-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.